A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Progression-free survival (PFS), event-free survival (EFS), and overall... | Download Scientific Diagram
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Association between event-free survival and overall survival in early-stage triple-negative breast cancer | Future Oncology
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
What is Disease Free Survival (DFS) and Event Free Survival (EFS) in clinical trials?
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Disease Free Survival - an overview | ScienceDirect Topics
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
